These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22578816)

  • 1. Syndrome of inappropriate antidiuretic hormone secretion due to marginal zone lymphoma: responding to rituximab.
    Bockorny B; Dasanu CA
    Clin Lymphoma Myeloma Leuk; 2012 Jun; 12(3):220-2. PubMed ID: 22578816
    [No Abstract]   [Full Text] [Related]  

  • 2. Syndrome of Inappropriate Antidiuretic Hormone Secretion in a Patient with Mucosa-associated Lymphoid Tissue Lymphoma.
    Shimizu N; Tanaka S; Watanabe Y; Tokuyama W; Hiruta N; Ohwada C; Sakaida E; Nakaseko C; Tatsuno I
    Intern Med; 2017 Dec; 56(23):3225-3229. PubMed ID: 29021471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired C1 esterase inhibitor deficiency in a marginal zone lymphoma patient treated with rituximab.
    Ates O; Sunar V; Babacan T; Akin S; Kertmen N; Altundag K
    J BUON; 2015; 20(1):349. PubMed ID: 25778339
    [No Abstract]   [Full Text] [Related]  

  • 4. Mucosa-associated lymphoid tissue (MALT) lymphoma presenting as subglottic stenosis: single-agent treatment using rituximab.
    Bielinski C; Luu HS; Mau T
    Otolaryngol Head Neck Surg; 2014 Feb; 150(2):334-5. PubMed ID: 24334958
    [No Abstract]   [Full Text] [Related]  

  • 5. Asian variant of intravascular large B cell lymphoma causes patients to frequently develop the syndrome of inappropriate antidiuretic hormone secretion.
    Onishi C; Ikejiri F; Kawakami K; Miyake T; Kumanomido S; Inoue M; Takahashi T; Tanaka J; Yamamoto M; Sugimoto T; Suzumiya J
    Ann Hematol; 2011 Nov; 90(11):1293-7. PubMed ID: 21340719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma.
    Else M; Marín-Niebla A; de la Cruz F; Batty P; Ríos E; Dearden CE; Catovsky D; Matutes E
    Br J Haematol; 2012 Nov; 159(3):322-8. PubMed ID: 23016878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission of acquired von Willebrand syndrome after successful treatment of gastric MALT lymphoma.
    Biondo F; Matturro A; Santoro C; Leporace A; D'Elia G; Baldacci E; Pignoloni P; Pulsoni A; Foà R; Mazzucconi M
    Haemophilia; 2012 Jan; 18(1):e34-5. PubMed ID: 22059776
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytotoxic T cell-mediated gastritis after rituximab treatment for gastric malt lymphoma.
    Stalika E; Kanellis G; Papalexandri A; Iskas M; Vrakidou E; Demonakou M; Anagnostopoulos A; Stamatopoulos K; Papadaki T
    Leuk Lymphoma; 2014 Mar; 55(3):702-5. PubMed ID: 23725385
    [No Abstract]   [Full Text] [Related]  

  • 9. Pneumocystis jirovecii pneumonia as a complication of bendamustine in a patient receiving bendamustine plus rituximab for marginal zone lymphoma.
    Carter SJ; Bernstein SH; Friedberg JW; Barr PM
    Leuk Res; 2011 Nov; 35(11):e223-4. PubMed ID: 21824654
    [No Abstract]   [Full Text] [Related]  

  • 10. Intralesional rituximab for primary iris lymphoma.
    Demirci H; Grant JS; Elner VM
    JAMA Ophthalmol; 2015 Jan; 133(1):104-5. PubMed ID: 25211092
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoimmune phenomena in untreated and treated marginal zone lymphoma.
    Grabska J; Dasanu CA
    Expert Opin Pharmacother; 2011 Oct; 12(15):2369-79. PubMed ID: 21679092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma.
    Olszewski AJ; Ali S
    Ann Hematol; 2014 Mar; 93(3):449-58. PubMed ID: 24057925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Successful treatment with rituximab in a patient with primary thymic MALT lymphoma complicated with acquired von Willebrand syndrome and Sjögren syndrome].
    Iwabuchi T; Kimura Y; Suzuki T; Hayashi H; Fujimoto H; Hashimoto Y; Ogawa T; Kusama H; Fukutake K; Ohyashiki K
    Rinsho Ketsueki; 2011 Apr; 52(4):210-5. PubMed ID: 21566407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report: Colonic MALT lymphoma.
    Khan M; Chon D; Patil A
    J Gastrointest Cancer; 2012 Dec; 43(4):622-5. PubMed ID: 22965352
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mucosa-associated lymphoid tissue (MALT) lymphoma of the lung treated by surgery and rituximab; report of a case].
    Yoshida C; Tarumi S; Kato A; Nii K; Chang SS; Yokomise H
    Kyobu Geka; 2013 Feb; 66(2):169-72. PubMed ID: 23381369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implication of the antidiuretic hormone (ADH) receptor antagonist mozavaptan hydrochloride in patients with ectopic ADH syndrome.
    ; Yamaguchi K; Shijubo N; Kodama T; Mori K; Sugiura T; Kuriyama T; Kawahara M; Shinkai T; Iguchi H; Sakurai M
    Jpn J Clin Oncol; 2011 Jan; 41(1):148-52. PubMed ID: 21087977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [SIADH (syndrome of inappropriate secretion of antidiuretic hormone)].
    Matsunaga T
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():441-4. PubMed ID: 25831799
    [No Abstract]   [Full Text] [Related]  

  • 18. Acquired angioedema and marginal zone lymphoma.
    Lam DH; Levy NB; Nickerson JM; Gruenberg DA; Lansigan F
    J Clin Oncol; 2012 Jun; 30(16):e151-3. PubMed ID: 22508826
    [No Abstract]   [Full Text] [Related]  

  • 19. Rituximab chemotherapy regimens for treating advanced follicular lymphoma evaluated in new study.
    Askeland G
    Expert Rev Clin Immunol; 2013 May; 9(5):402. PubMed ID: 23772446
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: treatment outcomes in extranodal marginal zone subtype.
    Portell CA; Aronow ME; Rybicki LA; Macklis R; Singh AD; Sweetenham JW
    Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):203-10. PubMed ID: 24417911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.